Allopurinol Add-on Treatment for Refractory Mania
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00643123 |
Recruitment Status :
Completed
First Posted : March 26, 2008
Results First Posted : April 13, 2018
Last Update Posted : May 8, 2019
|
Sponsor:
Cedars-Sinai Medical Center
Collaborator:
National Alliance for Research on Schizophrenia and Depression
Information provided by (Responsible Party):
Itai Danovitch, Cedars-Sinai Medical Center
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Double (Participant, Investigator); Primary Purpose: Treatment |
Conditions |
Bipolar Disorder Mixed Mania Treatment-Resistant Mania |
Interventions |
Drug: Allopurinol Other: Placebo |
Enrollment | 40 |
Participant Flow
Recruitment Details | |
Pre-assignment Details | 8 subjects screen failed; 5 subjects did not qualify at Baseline. 13 total subjects were not randomized |
Baseline Characteristics
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Felicia Mayes |
Organization: | Cedars Sinai Medical Center |
Phone: | 310-423-0825 |
EMail: | mayesf@cshs.org |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Itai Danovitch, Cedars-Sinai Medical Center |
ClinicalTrials.gov Identifier: | NCT00643123 History of Changes |
Other Study ID Numbers: |
IRB8981 |
First Submitted: | March 20, 2008 |
First Posted: | March 26, 2008 |
Results First Submitted: | January 24, 2018 |
Results First Posted: | April 13, 2018 |
Last Update Posted: | May 8, 2019 |